Source: Annual Congress 2012 - Tobacco cessation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Pinar Önen, E. Sen, B. Eris Gülbay, P. Akin Kabalak, O. Akkoca Yildiz, T. Acican, S. Saryal, G. Karabiyikoglu (Ankara, Turkey). Can we really relieve the withdrawal syndrome with pharmacotherapy in smoking cessation?. Eur Respir J 2012; 40: Suppl. 56, 4049

Member's Comments

No comment yet.

Related content which might interest you: Relation between smoking cessation therapy and nicotine withdrawal syndrome Source: Annual Congress 2010 - Smoking cessation interventions Year: 2010 Relation between successful smoking cessation and intensity of nicotine withdrawal syndrome Source: Annual Congress 2009 - Smoking cessation Year: 2009 Smoking cessation and prevention Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242 Year: 2006 Smoking cessation and COPD Source: Eur Respir Rev 2013; 22: 37-43 Year: 2013 Smoking cessation strategies in patients with COPD Source: Eur Respir J 2013; 41: 727-734 Year: 2013 Providing a rationale for the development of tailored smoking cessation interventions: the relationship between respiratory symptoms, depression and nicotine dependence Source: Eur Respir J 2002; 20: Suppl. 38, 204s Year: 2002 Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008 Causes of quitting treatment with varenicline in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Evaluation of prolonged bupropion treatment as an aid in smoking cessation Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002 Pharmacological treatment for smoking cessation Source: Eur Respir Mon; 2008: 42: 74–97 Year: 2008 Behavioural counselling for smoking cessation in respiratory patients and other interventions to reduce harm  Source: International Congress 2017 – PG14 Smoking cessation in patients with respiratory diseases Year: 2017 Does depression disorder have an important impact in smoking cessation? Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018 Effectiveness of smoking cessation in patients with psychiatric disease Source: Annual Congress 2012 - Tobacco comorbidity Year: 2012 Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Effectiveness of varenicline treatment in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Factors affecting the success of smoking cessation treatment in a smoking cessation clinic Source: International Congress 2017 – Smoking cessation Year: 2017 Smoking cessation guidelines in health and chronic diseases Source: Annual Congress 2006 - PG20 - Smoking cessation in a respiratory medicine setting Year: 2006